25 XP   0   0   10

Wave Life Sciences Ltd
Buy, Hold or Sell?

Let's analyse Wave Life Sciences Ltd together

PenkeI guess you are interested in Wave Life Sciences Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Wave Life Sciences Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Wave Life Sciences Ltd

I send you an email if I find something interesting about Wave Life Sciences Ltd.

Quick analysis of Wave Life Sciences Ltd (30 sec.)










What can you expect buying and holding a share of Wave Life Sciences Ltd? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.39
Expected worth in 1 year
$1.15
How sure are you?
36.8%

+ What do you gain per year?

Total Gains per Share
$0.76
Return On Investment
15.6%

For what price can you sell your share?

Current Price per Share
$4.84
Expected price per share
$3.5 - $6.32
How sure are you?
50%

1. Valuation of Wave Life Sciences Ltd (5 min.)




Live pricePrice per Share (EOD)

$4.84

Intrinsic Value Per Share

$-5.45 - $-6.28

Total Value Per Share

$-5.06 - $-5.89

2. Growth of Wave Life Sciences Ltd (5 min.)




Is Wave Life Sciences Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$47.5m-$4.6m-$15.1m-76.4%

How much money is Wave Life Sciences Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$13.6m-$30m$16.3m120.1%
Net Profit Margin-81.6%-4,840.5%--

How much money comes from the company's main activities?

3. Financial Health of Wave Life Sciences Ltd (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#480 / 1011

Most Revenue
#200 / 1011

Most Profit
#617 / 1011

Most Efficient
#554 / 1011

What can you expect buying and holding a share of Wave Life Sciences Ltd? (5 min.)

Welcome investor! Wave Life Sciences Ltd's management wants to use your money to grow the business. In return you get a share of Wave Life Sciences Ltd.

What can you expect buying and holding a share of Wave Life Sciences Ltd?

First you should know what it really means to hold a share of Wave Life Sciences Ltd. And how you can make/lose money.

Speculation

The Price per Share of Wave Life Sciences Ltd is $4.84. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Wave Life Sciences Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Wave Life Sciences Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.39. Based on the TTM, the Book Value Change Per Share is $0.19 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Wave Life Sciences Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.13-2.7%-0.12-2.4%-0.33-6.8%-0.28-5.8%-0.24-5.1%
Usd Book Value Change Per Share0.7214.9%0.193.9%-0.16-3.3%-0.01-0.2%0.010.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.7214.9%0.193.9%-0.16-3.3%-0.01-0.2%0.010.2%
Usd Price Per Share5.05-4.69-3.97-9.23-14.92-
Price to Earnings Ratio-9.50-1.16--2.94--6.79--15.32-
Price-to-Total Gains Ratio7.02-23.61--7.06-0.53--40.46-
Price to Book Ratio13.00--7.06--1,179.58--239.53--116.00-
Price-to-Total Gains Ratio7.02-23.61--7.06-0.53--40.46-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.84
Number of shares206
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.19-0.01
Usd Total Gains Per Share0.19-0.01
Gains per Quarter (206 shares)39.00-2.18
Gains per Year (206 shares)155.99-8.71
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101561460-9-19
203123020-17-28
304684580-26-37
406246140-35-46
507807700-44-55
609369260-52-64
70109210820-61-73
80124812380-70-82
90140413940-78-91
100156015500-87-100

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%1.011.00.08.3%1.019.00.05.0%1.037.00.02.6%1.037.01.02.6%
Book Value Change Per Share3.01.00.075.0%6.06.00.050.0%8.012.00.040.0%14.022.02.036.8%14.023.02.035.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.038.00.0%0.00.039.00.0%
Total Gains per Share3.01.00.075.0%6.06.00.050.0%8.012.00.040.0%14.022.02.036.8%14.023.02.035.9%

Fundamentals of Wave Life Sciences Ltd

About Wave Life Sciences Ltd

Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and commercializes ribonucleic acid (RNA) medicines through PRISM, a discovery and drug development platform. The company's RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. It is developing WVE-006, a RNA editing oligonucleotide for the treatment of alpha-1 antitrypsin deficiency; siRNA clinical candidate for the treatment of obesity and other metabolic disorders; WVE-N531, a exon skipping oligonucleotide for the treatment of duchenne muscular dystrophy; and WVE-003, an antisense silencing oligonucleotide for the treatment of Huntington's disease (HD). The company has collaboration agreements with GlaxoSmithKline for the research, development, and commercialization of oligonucleotide therapeutics; Takeda Pharmaceutical Company Limited for the research, development, and commercialization of oligonucleotide therapeutics for disorders of the Central Nervous System; and Asuragen, Inc. for the development and potential commercialization of companion diagnostics for investigational allele-selective therapeutic programs targeting HD. Wave Life Sciences Ltd. was incorporated in 2012 and is based in Singapore.

Fundamental data was last updated by Penke on 2024-04-12 22:35:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Wave Life Sciences Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Wave Life Sciences Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Wave Life Sciences Ltd to the Biotechnology industry mean.
  • A Net Profit Margin of -55.9% means that $-0.56 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Wave Life Sciences Ltd:

  • The MRQ is -55.9%. The company is making a huge loss. -2
  • The TTM is -81.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-55.9%TTM-81.6%+25.6%
TTM-81.6%YOY-4,840.5%+4,758.9%
TTM-81.6%5Y-1,668.8%+1,587.2%
5Y-1,668.8%10Y-2,788.4%+1,119.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-55.9%-196.1%+140.2%
TTM-81.6%-211.9%+130.3%
YOY-4,840.5%-277.7%-4,562.8%
5Y-1,668.8%-432.9%-1,235.9%
10Y-2,788.4%-599.3%-2,189.1%
1.1.2. Return on Assets

Shows how efficient Wave Life Sciences Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Wave Life Sciences Ltd to the Biotechnology industry mean.
  • -5.9% Return on Assets means that Wave Life Sciences Ltd generated $-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Wave Life Sciences Ltd:

  • The MRQ is -5.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.9%TTM-5.2%-0.8%
TTM-5.2%YOY-18.4%+13.3%
TTM-5.2%5Y-13.4%+8.2%
5Y-13.4%10Y-18.2%+4.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.9%-13.3%+7.4%
TTM-5.2%-12.7%+7.5%
YOY-18.4%-11.8%-6.6%
5Y-13.4%-14.0%+0.6%
10Y-18.2%-15.9%-2.3%
1.1.3. Return on Equity

Shows how efficient Wave Life Sciences Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Wave Life Sciences Ltd to the Biotechnology industry mean.
  • -34.2% Return on Equity means Wave Life Sciences Ltd generated $-0.34 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Wave Life Sciences Ltd:

  • The MRQ is -34.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -8.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-34.2%TTM-8.6%-25.7%
TTM-8.6%YOY0.1%-8.7%
TTM-8.6%5Y-44.7%+36.2%
5Y-44.7%10Y-38.1%-6.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-34.2%-16.9%-17.3%
TTM-8.6%-16.0%+7.4%
YOY0.1%-15.1%+15.2%
5Y-44.7%-19.7%-25.0%
10Y-38.1%-20.5%-17.6%

1.2. Operating Efficiency of Wave Life Sciences Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Wave Life Sciences Ltd is operating .

  • Measures how much profit Wave Life Sciences Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Wave Life Sciences Ltd to the Biotechnology industry mean.
  • An Operating Margin of -64.3% means the company generated $-0.64  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Wave Life Sciences Ltd:

  • The MRQ is -64.3%. The company is operating very inefficient. -2
  • The TTM is -105.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-64.3%TTM-105.2%+40.9%
TTM-105.2%YOY-7,696.7%+7,591.4%
TTM-105.2%5Y-2,306.2%+2,200.9%
5Y-2,306.2%10Y-3,150.4%+844.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-64.3%-290.9%+226.6%
TTM-105.2%-224.4%+119.2%
YOY-7,696.7%-288.3%-7,408.4%
5Y-2,306.2%-479.5%-1,826.7%
10Y-3,150.4%-625.2%-2,525.2%
1.2.2. Operating Ratio

Measures how efficient Wave Life Sciences Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.64 means that the operating costs are $1.64 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Wave Life Sciences Ltd:

  • The MRQ is 1.643. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.074. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.643TTM2.074-0.431
TTM2.074YOY100.070-97.996
TTM2.0745Y30.857-28.782
5Y30.85710Y54.585-23.729
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6433.110-1.467
TTM2.0743.266-1.192
YOY100.0703.783+96.287
5Y30.8575.657+25.200
10Y54.5857.783+46.802

1.3. Liquidity of Wave Life Sciences Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Wave Life Sciences Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.26 means the company has $1.26 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Wave Life Sciences Ltd:

  • The MRQ is 1.262. The company is just able to pay all its short-term debts.
  • The TTM is 1.456. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.262TTM1.456-0.193
TTM1.456YOY2.012-0.557
TTM1.4565Y2.191-0.735
5Y2.19110Y6.810-4.619
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2623.905-2.643
TTM1.4564.212-2.756
YOY2.0125.337-3.325
5Y2.1916.062-3.871
10Y6.8106.401+0.409
1.3.2. Quick Ratio

Measures if Wave Life Sciences Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Wave Life Sciences Ltd to the Biotechnology industry mean.
  • A Quick Ratio of 1.19 means the company can pay off $1.19 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Wave Life Sciences Ltd:

  • The MRQ is 1.188. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.364. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.188TTM1.364-0.176
TTM1.364YOY2.248-0.884
TTM1.3645Y2.111-0.747
5Y2.11110Y6.675-4.564
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1883.572-2.384
TTM1.3644.001-2.637
YOY2.2485.364-3.116
5Y2.1116.009-3.898
10Y6.6756.287+0.388

1.4. Solvency of Wave Life Sciences Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Wave Life Sciences Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Wave Life Sciences Ltd to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.83 means that Wave Life Sciences Ltd assets are financed with 82.7% credit (debt) and the remaining percentage (100% - 82.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Wave Life Sciences Ltd:

  • The MRQ is 0.827. The company is just able to pay all its debts by selling its assets.
  • The TTM is 1.096. The company is just not able to pay all its debts by selling its assets. -1
Trends
Current periodCompared to+/- 
MRQ0.827TTM1.096-0.269
TTM1.096YOY1.047+0.049
TTM1.0965Y0.890+0.206
5Y0.89010Y0.730+0.160
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8270.336+0.491
TTM1.0960.334+0.762
YOY1.0470.271+0.776
5Y0.8900.366+0.524
10Y0.7300.389+0.341
1.4.2. Debt to Equity Ratio

Measures if Wave Life Sciences Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Wave Life Sciences Ltd to the Biotechnology industry mean.
  • A Debt to Equity ratio of 478.8% means that company has $4.79 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Wave Life Sciences Ltd:

  • The MRQ is 4.788. The company is unable to pay all its debts with equity. -1
  • The TTM is 1.197. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ4.788TTM1.197+3.591
TTM1.197YOY1.473-0.276
TTM1.1975Y2.828-1.631
5Y2.82810Y1.749+1.079
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.7880.382+4.406
TTM1.1970.397+0.800
YOY1.4730.341+1.132
5Y2.8280.432+2.396
10Y1.7490.465+1.284

2. Market Valuation of Wave Life Sciences Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Wave Life Sciences Ltd generates.

  • Above 15 is considered overpriced but always compare Wave Life Sciences Ltd to the Biotechnology industry mean.
  • A PE ratio of -9.50 means the investor is paying $-9.50 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Wave Life Sciences Ltd:

  • The EOD is -9.102. Based on the earnings, the company is expensive. -2
  • The MRQ is -9.497. Based on the earnings, the company is expensive. -2
  • The TTM is 1.160. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-9.102MRQ-9.497+0.395
MRQ-9.497TTM1.160-10.657
TTM1.160YOY-2.937+4.097
TTM1.1605Y-6.793+7.953
5Y-6.79310Y-15.324+8.531
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-9.102-2.262-6.840
MRQ-9.497-2.599-6.898
TTM1.160-2.674+3.834
YOY-2.937-4.133+1.196
5Y-6.793-6.258-0.535
10Y-15.324-6.171-9.153
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Wave Life Sciences Ltd:

  • The EOD is -4.428. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -4.621. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.779. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.428MRQ-4.621+0.192
MRQ-4.621TTM-2.779-1.841
TTM-2.779YOY-3.876+1.097
TTM-2.7795Y-8.710+5.931
5Y-8.71010Y-51.088+42.377
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.428-2.913-1.515
MRQ-4.621-3.275-1.346
TTM-2.779-3.508+0.729
YOY-3.876-5.620+1.744
5Y-8.710-8.306-0.404
10Y-51.088-8.854-42.234
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Wave Life Sciences Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 13.00 means the investor is paying $13.00 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Wave Life Sciences Ltd:

  • The EOD is 12.459. Based on the equity, the company is expensive. -2
  • The MRQ is 13.000. Based on the equity, the company is expensive. -2
  • The TTM is -7.057. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD12.459MRQ13.000-0.541
MRQ13.000TTM-7.057+20.056
TTM-7.057YOY-1,179.580+1,172.523
TTM-7.0575Y-239.527+232.471
5Y-239.52710Y-116.000-123.528
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD12.4591.858+10.601
MRQ13.0002.090+10.910
TTM-7.0572.091-9.148
YOY-1,179.5802.866-1,182.446
5Y-239.5273.488-243.015
10Y-116.0003.836-119.836
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Wave Life Sciences Ltd.

3.1. Institutions holding Wave Life Sciences Ltd

Institutions are holding 74.844% of the shares of Wave Life Sciences Ltd.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31RA Capital Management, LLC14.8851.43571820200910000005.8133
2023-12-31Maverick Capital Ltd6.90830.85678447804185348528.1073
2023-12-31M28 Capital Management LP6.029730.848473734133289134.6691
2023-12-31Adage Capital Partners Gp LLC4.89660.06265987730220000058.0823
2023-12-31683 Capital Management LLC4.57952.31625600000-250000-4.2735
2023-12-31BlackRock Inc4.38840.0007536628850252210.332
2023-12-31Bellevue Group AG3.67540.3472449445800
2023-12-31Kynam Capital Management, LP3.21552.1999393208200
2023-12-31PRIMECAP Management Company3.07430.0153759408-21100-0.5581
2023-12-31Artal Group S A2.45940.50493007400100740050.37
2023-12-31T. Rowe Price Associates, Inc.1.33080.0011162736335820128.2234
2023-12-31Geode Capital Management, LLC1.19370.00081459764646274.6323
2023-12-31MAVEN SECURITIES Ltd1.1880.1519145277814527780
2023-12-31Woodline Partners LP1.1380.0764139156116287813.2563
2023-12-31Vanguard Group Inc1.07330.0001131242512982310.9777
2023-12-31State Street Corporation1.03340.00031263729689825.7738
2023-12-31FMR Inc0.98310.0005120221554179082.0366
2023-09-30LAURION CAPITAL MANAGEMENT LP0.71270.0306871500426625.1472
2023-12-31Goldman Sachs Group Inc0.63970.0004782264440470128.87
2023-12-31Junked Platinum Investment Management Ltd0.53590.134465533120000043.9241
Total 63.940738.983878189522+10083431+12.9%

3.2. Funds holding Wave Life Sciences Ltd

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30BB Biotech AG Ord3.67541.0594449445800
2023-12-31PRIMECAP Odyssey Aggressive Growth2.68450.23073282770-13000-0.3944
2024-02-29iShares Russell 2000 ETF1.14170.01081396060-228-0.0163
2024-01-31Fidelity Select Biotechnology0.92510.1059113131100
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.79420.0046971133-1583-0.1627
2024-02-29iShares Biotechnology ETF0.54150.0419662143-2980-0.448
2023-12-31Fidelity Small Cap Index0.49110.0119600509117862.002
2024-02-01iShares Russell 2000 Value ETF0.45430.01885555427020.1265
2024-02-29JPM Thematics Genetic Thrps C2 Acc USD0.32350.2533395566-5985-1.4905
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.30090.0042367900167004.7551
2024-01-31Fidelity Extended Market Index0.29330.004335863200
2024-02-29SEI Tax-Managed Small/Mid Cap F (SIMT)0.2130.147426041700
2023-12-31Vanguard US Opportunities Ins USD Acc0.21290.1049260338-1000-0.3826
2024-02-29State St Russell Sm Cap® Indx SL Cl I0.18870.011823080000
2024-02-29Vanguard Russell 2000 ETF0.17580.0108214962167328.4407
2023-12-31NT R2000 Value Index Fund - NL0.13720.0224167813-5400-3.1175
2023-12-31NT R2000 Index Fund - NL0.13630.0116166623-5136-2.9902
2023-09-30BlackRock Extended Mkt Composite0.12710.006315547510350.6702
2023-12-31BlackRock Extended Equity Market K0.10970.0049134116-270-0.2009
2024-02-29Schwab Small Cap Index0.10960.0109133990-5728-4.0997
Total 13.03582.076815940558+5645+0.0%

3.3. Insider Transactions

Insiders are holding 18.216% of the shares of Wave Life Sciences Ltd.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-03Kyle MoranSELL156306.17
2023-12-11Ra Capital Management, L.p.BUY10000005
2023-08-23Kyle MoranSELL370624.75

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Wave Life Sciences Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.7200.189+280%-0.159+122%-0.011+101%0.012+5950%
Book Value Per Share--0.388-0.162+142%-0.038+110%0.320+22%0.555-30%
Current Ratio--1.2621.456-13%2.012-37%2.191-42%6.810-81%
Debt To Asset Ratio--0.8271.096-25%1.047-21%0.890-7%0.730+13%
Debt To Equity Ratio--4.7881.197+300%1.473+225%2.828+69%1.749+174%
Dividend Per Share----0%-0%-0%-0%
Eps---0.133-0.118-12%-0.331+149%-0.280+111%-0.244+84%
Free Cash Flow Per Share---0.273-0.042-85%-0.264-3%-0.224-18%-0.159-42%
Free Cash Flow To Equity Per Share--0.4910.228+115%-0.127+126%0.010+4615%0.044+1010%
Gross Profit Margin--1.1341.034+10%1.000+13%1.007+13%1.004+13%
Intrinsic Value_10Y_max---6.282--------
Intrinsic Value_10Y_min---5.451--------
Intrinsic Value_1Y_max---0.649--------
Intrinsic Value_1Y_min---0.638--------
Intrinsic Value_3Y_max---1.936--------
Intrinsic Value_3Y_min---1.848--------
Intrinsic Value_5Y_max---3.204--------
Intrinsic Value_5Y_min---2.975--------
Market Cap591854560.000-4%617534200.000573817670.000+8%484856060.000+27%1128467323.000-45%1824750810.000-66%
Net Profit Margin---0.559-0.816+46%-48.405+8552%-16.688+2883%-27.884+4884%
Operating Margin---0.643-1.052+64%-76.967+11871%-23.062+3487%-31.504+4800%
Operating Ratio--1.6432.074-21%100.070-98%30.857-95%54.585-97%
Pb Ratio12.459-4%13.000-7.057+154%-1179.580+9174%-239.527+1943%-116.000+992%
Pe Ratio-9.102+4%-9.4971.160-919%-2.937-69%-6.793-28%-15.324+61%
Price Per Share4.840-4%5.0504.693+8%3.965+27%9.228-45%14.922-66%
Price To Free Cash Flow Ratio-4.428+4%-4.621-2.779-40%-3.876-16%-8.710+89%-51.088+1006%
Price To Total Gains Ratio6.726-4%7.01823.615-70%-7.060+201%0.532+1220%-40.460+677%
Quick Ratio--1.1881.364-13%2.248-47%2.111-44%6.675-82%
Return On Assets---0.059-0.052-13%-0.184+212%-0.134+126%-0.182+207%
Return On Equity---0.342-0.086-75%0.001-34262%-0.447+31%-0.381+11%
Total Gains Per Share--0.7200.189+280%-0.159+122%-0.011+101%0.012+5950%
Usd Book Value--47504000.000-19854000.000+142%-4679000.000+110%39095150.000+22%67823500.000-30%
Usd Book Value Change Per Share--0.7200.189+280%-0.159+122%-0.011+101%0.012+5950%
Usd Book Value Per Share--0.388-0.162+142%-0.038+110%0.320+22%0.555-30%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.133-0.118-12%-0.331+149%-0.280+111%-0.244+84%
Usd Free Cash Flow---33412370.000-5090842.500-85%-32285500.000-3%-27426368.500-18%-19426509.737-42%
Usd Free Cash Flow Per Share---0.273-0.042-85%-0.264-3%-0.224-18%-0.159-42%
Usd Free Cash Flow To Equity Per Share--0.4910.228+115%-0.127+126%0.010+4615%0.044+1010%
Usd Market Cap591854560.000-4%617534200.000573817670.000+8%484856060.000+27%1128467323.000-45%1824750810.000-66%
Usd Price Per Share4.840-4%5.0504.693+8%3.965+27%9.228-45%14.922-66%
Usd Profit---16256000.000-13658250.000-16%-30057000.000+85%-32032700.000+97%-25448815.789+57%
Usd Revenue--29056000.00028326250.000+3%912250.000+3085%10170850.000+186%5881631.579+394%
Usd Total Gains Per Share--0.7200.189+280%-0.159+122%-0.011+101%0.012+5950%
 EOD+2 -6MRQTTM+20 -14YOY+25 -95Y+23 -1110Y+18 -16

4.2. Fundamental Score

Let's check the fundamental score of Wave Life Sciences Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-9.102
Price to Book Ratio (EOD)Between0-112.459
Net Profit Margin (MRQ)Greater than0-0.559
Operating Margin (MRQ)Greater than0-0.643
Quick Ratio (MRQ)Greater than11.188
Current Ratio (MRQ)Greater than11.262
Debt to Asset Ratio (MRQ)Less than10.827
Debt to Equity Ratio (MRQ)Less than14.788
Return on Equity (MRQ)Greater than0.15-0.342
Return on Assets (MRQ)Greater than0.05-0.059
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Wave Life Sciences Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.096
Ma 20Greater thanMa 505.684
Ma 50Greater thanMa 1005.409
Ma 100Greater thanMa 2005.116
OpenGreater thanClose4.920
Total4/5 (80.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Total Stockholder Equity -45,09110,377-34,714-17,006-51,72011,234-40,48687,99047,504
Net Invested Capital  -45,09110,377-34,714-17,006-51,72011,234-40,48680,11639,630



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets274,949
Total Liabilities227,445
Total Stockholder Equity47,504
 As reported
Total Liabilities 227,445
Total Stockholder Equity+ 47,504
Total Assets = 274,949

Assets

Total Assets274,949
Total Current Assets235,373
Long-term Assets39,576
Total Current Assets
Cash And Cash Equivalents 200,351
Net Receivables 21,086
Other Current Assets 13,936
Total Current Assets  (as reported)235,373
Total Current Assets  (calculated)235,373
+/-0
Long-term Assets
Property Plant Equipment 35,721
Long-term Assets Other 156
Long-term Assets  (as reported)39,576
Long-term Assets  (calculated)35,877
+/- 3,699

Liabilities & Shareholders' Equity

Total Current Liabilities186,440
Long-term Liabilities41,005
Total Stockholder Equity47,504
Total Current Liabilities
Short-term Debt 6,714
Accounts payable 12,839
Other Current Liabilities 16,828
Total Current Liabilities  (as reported)186,440
Total Current Liabilities  (calculated)36,381
+/- 150,059
Long-term Liabilities
Capital Lease Obligations 32,118
Long-term Liabilities  (as reported)41,005
Long-term Liabilities  (calculated)32,118
+/- 8,887
Total Stockholder Equity
Common Stock935,367
Retained Earnings -1,024,850
Other Stockholders Equity 129,237
Total Stockholder Equity (as reported)47,504
Total Stockholder Equity (calculated)39,754
+/- 7,750
Other
Capital Stock935,367
Cash and Short Term Investments 200,351
Common Stock Shares Outstanding 109,628
Current Deferred Revenue150,059
Liabilities and Stockholders Equity 274,949
Net Debt -168,233
Net Invested Capital 39,630
Net Working Capital 48,933
Property Plant and Equipment Gross 78,430
Short Long Term Debt Total 32,118



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302013-12-31
> Total Assets 
2,323
0
2,938
0
11,596
70,996
165,424
158,522
190,338
179,973
164,811
151,507
226,432
202,086
181,843
150,421
353,743
324,577
295,940
430,612
385,547
347,212
284,250
238,572
203,951
310,061
279,238
242,647
206,411
200,512
207,007
167,359
213,319
181,511
146,386
267,270
229,985
199,918
274,949
274,949199,918229,985267,270146,386181,511213,319167,359207,007200,512206,411242,647279,238310,061203,951238,572284,250347,212385,547430,612295,940324,577353,743150,421181,843202,086226,432151,507164,811179,973190,338158,522165,42470,99611,59602,93802,323
   > Total Current Assets 
0
0
1,487
0
8,626
67,987
161,384
154,000
183,941
172,140
151,990
132,780
201,224
173,834
150,488
117,961
267,674
233,161
202,273
315,031
289,591
250,258
185,476
149,791
146,834
258,430
230,042
194,545
159,431
157,987
162,564
124,383
160,114
131,434
98,537
219,591
184,708
158,572
235,373
235,373158,572184,708219,59198,537131,434160,114124,383162,564157,987159,431194,545230,042258,430146,834149,791185,476250,258289,591315,031202,273233,161267,674117,961150,488173,834201,224132,780151,990172,140183,941154,000161,38467,9878,62601,48700
       Cash And Cash Equivalents 
439
0
1,048
0
7,779
66,040
161,220
153,397
181,765
169,015
150,293
129,484
197,394
168,464
142,503
110,491
241,431
210,489
174,819
287,567
252,906
209,009
147,161
120,949
94,054
216,363
184,497
148,535
143,840
123,896
150,564
61,713
123,163
96,954
88,497
207,562
172,974
139,942
200,351
200,351139,942172,974207,56288,49796,954123,16361,713150,564123,896143,840148,535184,497216,36394,054120,949147,161209,009252,906287,567174,819210,489241,431110,491142,503168,464197,394129,484150,293169,015181,765153,397161,22066,0407,77901,0480439
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50,000
25,000
25,044
0
0
0
0
0
0000025,04425,00050,0000000000000000000000000000000000
       Net Receivables 
0
0
200
0
0
64
18
23
2,500
2,500
214
0
0
0
1,000
1,000
15,000
10,000
10,000
10,000
20,000
20,000
20,000
18,796
46,255
30,000
30,000
30,000
0
22,500
0
0
0
0
0
0
0
7,000
21,086
21,0867,000000000022,500030,00030,00030,00046,25518,79620,00020,00020,00010,00010,00010,00015,0001,0001,0000002142,5002,5002318640020000
       Inventory 
0
0
167
0
0
0
0
0
0
25
0
0
0
0
-15
0
-57
0
0
0
0
0
9,626
9,999
6,452
7,966
10,434
10,430
0
7,627
0
0
0
0
0
0
0
7,514
0
07,51400000007,627010,43010,4347,9666,4529,9999,62600000-570-1500002500000016700
   > Long-term Assets 
0
0
1,451
0
2,970
3,009
4,040
4,522
6,397
7,833
12,821
18,727
25,208
28,252
31,355
32,460
86,069
91,416
93,667
115,581
95,956
96,954
98,774
88,781
57,117
51,631
49,196
48,102
46,980
42,525
44,443
42,976
53,205
50,077
47,849
47,679
45,277
41,346
39,576
39,57641,34645,27747,67947,84950,07753,20542,97644,44342,52546,98048,10249,19651,63157,11788,78198,77496,95495,956115,58193,66791,41686,06932,46031,35528,25225,20818,72712,8217,8336,3974,5224,0403,0092,97001,45100
       Property Plant Equipment 
1,384
0
1,269
0
1,832
1,954
2,789
3,218
5,093
6,693
8,607
14,296
20,775
24,584
27,334
28,778
32,384
37,722
39,931
59,262
57,300
55,731
54,469
52,645
50,297
47,841
45,430
43,090
41,031
38,659
40,644
38,640
48,599
46,379
44,127
41,843
39,788
37,508
35,721
35,72137,50839,78841,84344,12746,37948,59938,64040,64438,65941,03143,09045,43047,84150,29752,64554,46955,73157,30059,26239,93137,72232,38428,77827,33424,58420,77514,2968,6076,6935,0933,2182,7891,9541,83201,26901,384
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50,000
50,000
50,000
50,000
0
30,000
0
30,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000030,000030,000050,00050,00050,00050,0000000000000000000
       Long-term Assets Other 
0
0
0
0
1,055
991
1,059
1,112
1,112
1,108
3,654
3,657
3,659
3,668
4,021
3,682
53,685
53,694
53,736
56,319
38,656
41,223
44,305
36,136
6,820
3,790
3,766
5,012
5,949
3,866
3,799
4,336
955
44
62
1,176
1,821
155
156
1561551,8211,17662449554,3363,7993,8665,9495,0123,7663,7906,82036,13644,30541,22338,65656,31953,73653,69453,6853,6824,0213,6683,6593,6573,6541,1081,1121,1121,0599911,0550000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
192
192
192
32
560
774
774
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000077477456032192192192000000
> Total Liabilities 
10,085
0
911
0
2,633
74,116
11,933
12,001
24,060
28,839
29,948
34,420
37,520
36,230
42,029
40,372
214,447
217,971
222,592
233,756
225,323
232,439
220,518
217,714
208,440
201,820
196,460
189,826
184,569
170,611
174,509
167,412
182,372
186,030
191,477
301,984
281,705
240,404
227,445
227,445240,404281,705301,984191,477186,030182,372167,412174,509170,611184,569189,826196,460201,820208,440217,714220,518232,439225,323233,756222,592217,971214,44740,37242,02936,23037,52034,42029,94828,83924,06012,00111,93374,1162,6330911010,085
   > Total Current Liabilities 
10,049
0
882
0
2,492
3,474
3,818
3,770
8,647
11,425
12,155
14,070
15,555
15,122
19,621
16,298
43,781
125,795
130,041
131,877
124,084
133,411
118,153
118,881
110,452
109,664
121,040
48,680
46,721
31,640
64,201
58,486
64,082
64,259
71,521
132,566
140,226
99,980
186,440
186,44099,980140,226132,56671,52164,25964,08258,48664,20131,64046,72148,680121,040109,664110,452118,881118,153133,411124,084131,877130,041125,79543,78116,29819,62115,12215,55514,07012,15511,4258,6473,7703,8183,4742,4920882010,049
       Short-term Debt 
0
0
428
0
62
62
62
62
62
62
62
179
278
709
360
478
762
997
1,156
2,919
3,024
3,132
3,243
3,357
3,473
3,591
3,714
3,838
3,966
4,097
4,961
5,120
4,363
4,928
5,496
6,078
6,285
6,497
6,714
6,7146,4976,2856,0785,4964,9284,3635,1204,9614,0973,9663,8383,7143,5913,4733,3573,2433,1323,0242,9191,15699776247836070927817962626262626262042800
       Short Long Term Debt 
0
0
62
0
0
0
140
62
62
62
78
179
47
31
16
478
0
0
0
2,919
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000002,919000478163147179786262621400006200
       Accounts payable 
176
0
125
0
2,057
2,875
2,811
2,437
3,899
3,825
4,943
7,397
7,983
4,705
7,598
8,014
7,151
11,961
13,089
14,577
11,464
20,219
9,073
16,486
13,910
9,699
13,795
13,418
8,655
7,443
7,281
9,853
11,168
15,934
16,915
11,906
12,379
12,608
12,839
12,83912,60812,37911,90616,91515,93411,1689,8537,2817,4438,65513,41813,7959,69913,91016,4869,07320,21911,46414,57713,08911,9617,1518,0147,5984,7057,9837,3974,9433,8253,8992,4372,8112,8752,05701250176
       Other Current Liabilities 
271
0
177
0
215
406
354
1,338
2,186
4,833
4,445
3,789
4,589
7,003
8,958
6,531
8,574
9,608
14,851
8,490
11,632
13,738
16,185
10,994
8,220
10,182
11,971
6,661
9,923
11,364
14,861
7,087
11,085
11,056
17,552
7,622
10,429
12,624
16,828
16,82812,62410,4297,62217,55211,05611,0857,08714,86111,3649,9236,66111,97110,1828,22010,99416,18513,73811,6328,49014,8519,6088,5746,5318,9587,0034,5893,7894,4454,8332,1861,33835440621501770271
   > Long-term Liabilities 
0
0
29
0
141
70,642
8,115
8,231
15,413
17,414
17,793
20,350
21,965
21,108
22,408
24,074
170,666
92,176
92,551
101,879
101,239
99,028
102,365
98,833
97,988
92,156
75,420
141,146
137,848
138,971
110,308
108,926
118,290
121,771
119,956
169,418
141,479
140,424
41,005
41,005140,424141,479169,418119,956121,771118,290108,926110,308138,971137,848141,14675,42092,15697,98898,833102,36599,028101,239101,87992,55192,176170,66624,07422,40821,10821,96520,35017,79317,41415,4138,2318,11570,64214102900
       Long term Debt Total 
0
0
0
0
0
94
78
62
47
31
16
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000016314762789400000
       Capital Lease Obligations Min Short Term Debt
0
0
-428
0
-62
32
16
0
-15
-31
-46
-179
-278
-709
-360
-478
-762
-997
-1,156
31,782
30,985
30,165
29,304
28,425
27,513
26,574
25,591
24,587
23,547
22,477
24,955
23,617
35,160
33,667
32,118
30,534
28,875
27,170
25,404
25,40427,17028,87530,53432,11833,66735,16023,61724,95522,47723,54724,58725,59126,57427,51328,42529,30430,16530,98531,782-1,156-997-762-478-360-709-278-179-46-31-1501632-620-42800
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
192
192
192
32
560
774
774
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000077477456032192192192000000
       Warrants
0
0
0
0
0
70,517
7,874
7,874
7,874
7,874
7,874
7,874
7,874
7,874
7,874
7,874
7,874
7,874
7,874
7,874
0
7,874
0
7,874
7,874
7,874
7,874
7,874
7,874
7,874
7,874
0
7,874
7,874
7,874
7,874
7,874
0
0
007,8747,8747,8747,8747,87407,8747,8747,8747,8747,8747,8747,8747,87407,87407,8747,8747,8747,8747,8747,8747,8747,8747,8747,8747,8747,8747,8747,87470,51700000
       Long-term Liabilities Other 
0
0
0
0
0
31
163
295
409
522
1,592
3,130
4,268
3,114
4,713
5,790
157,928
79,218
79,545
2,039
1,897
1,793
1,721
1,621
1,520
84,282
67,546
133,272
339
131,097
102,434
868
110,416
113,897
112,082
161,544
133,605
0
0
00133,605161,544112,082113,897110,416868102,434131,097339133,27267,54684,2821,5201,6211,7211,7931,8972,03979,54579,218157,9285,7904,7133,1144,2683,1301,5925224092951633100000
       Deferred Long Term Liability 
0
0
8,311
0
0
0
0
0
7,083
8,987
8,311
9,346
9,823
10,120
9,821
10,410
4,864
5,084
5,132
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000005,1325,0844,86410,4109,82110,1209,8239,3468,3118,9877,083000008,31100
> Total Stockholder Equity
0
0
2,027
0
8,963
-3,120
153,491
146,521
166,278
151,134
134,863
117,087
188,912
165,856
139,814
110,049
139,296
106,606
73,348
196,856
160,224
114,773
63,732
20,858
-4,489
108,241
82,778
52,821
21,842
29,901
32,498
-53
30,947
-4,519
-45,091
-34,714
-51,720
-40,486
47,504
47,504-40,486-51,720-34,714-45,091-4,51930,947-5332,49829,90121,84252,82182,778108,241-4,48920,85863,732114,773160,224196,85673,348106,606139,296110,049139,814165,856188,912117,087134,863151,134166,278146,521153,491-3,1208,96302,02700
   Retained Earnings -1,024,850-1,008,594-1,015,846-994,742-967,337-923,628-884,624-843,328-805,514-770,729-764,499-725,733-683,269-654,480-621,380-580,852-533,359-476,589-425,863-383,921-339,721-301,834-264,203-228,309-192,512-162,301-136,166-111,473-90,477-72,023-54,488-42,923-35,076-27,977-23,0410-15,87600
   Accumulated Other Comprehensive Income 
0
0
56
0
34
43
41
52
76
84
-291
-276
-273
-272
116
165
201
181
153
250
280
282
267
273
278
301
389
269
269
258
181
95
-47
-123
-29
-50
-150
-182
-124
-124-182-150-50-29-123-4795181258269269389301278273267282280250153181201165116-272-273-276-29184765241433405600
   Capital Surplus 
0
0
0
0
0
2,368
3,182
4,048
5,318
7,568
10,029
13,028
15,996
18,995
22,172
26,602
30,147
33,757
37,768
42,113
47,270
52,290
57,277
61,276
65,070
68,354
71,573
75,636
78,358
84,254
87,980
0
113,169
116,535
119,442
122,192
124,601
0
0
00124,601122,192119,442116,535113,169087,98084,25478,35875,63671,57368,35465,07061,27657,27752,29047,27042,11337,76833,75730,14726,60222,17218,99515,99613,02810,0297,5685,3184,0483,1822,36800000
   Treasury Stock000000000000000000000000000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue113,305
Cost of Revenue-9,206
Gross Profit104,099104,099
 
Operating Income (+$)
Gross Profit104,099
Operating Expense-172,095
Operating Income-67,996-67,996
 
Operating Expense (+$)
Research Development130,009
Selling General Administrative51,292
Selling And Marketing Expenses9,206
Operating Expense172,095190,507
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-67,996
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-58,190-77,802
EBIT - interestExpense = -67,996
-58,190
-57,513
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-67,996-58,190
Earnings Before Interest and Taxes (EBITDA)-58,790
 
After tax Income (+$)
Income Before Tax-58,190
Tax Provision--677
Net Income From Continuing Ops-57,513-57,513
Net Income-57,513
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses181,301
Total Other Income/Expenses Net9,8060
 

Technical Analysis of Wave Life Sciences Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Wave Life Sciences Ltd. The general trend of Wave Life Sciences Ltd is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Wave Life Sciences Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Wave Life Sciences Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 5.57 < 6.13 < 6.32.

The bearish price targets are: 4.16 > 4.16 > 3.5.

Tweet this
Wave Life Sciences Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Wave Life Sciences Ltd. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Wave Life Sciences Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Wave Life Sciences Ltd. The current macd is -0.20151681.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Wave Life Sciences Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Wave Life Sciences Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Wave Life Sciences Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Wave Life Sciences Ltd Daily Moving Average Convergence/Divergence (MACD) ChartWave Life Sciences Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Wave Life Sciences Ltd. The current adx is 24.44.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Wave Life Sciences Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Wave Life Sciences Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Wave Life Sciences Ltd. The current sar is 5.81075399.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Wave Life Sciences Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Wave Life Sciences Ltd. The current rsi is 35.10. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Wave Life Sciences Ltd Daily Relative Strength Index (RSI) ChartWave Life Sciences Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Wave Life Sciences Ltd. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Wave Life Sciences Ltd price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Wave Life Sciences Ltd Daily Stochastic Oscillator ChartWave Life Sciences Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Wave Life Sciences Ltd. The current cci is -163.53028701.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Wave Life Sciences Ltd Daily Commodity Channel Index (CCI) ChartWave Life Sciences Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Wave Life Sciences Ltd. The current cmo is -46.88017587.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Wave Life Sciences Ltd Daily Chande Momentum Oscillator (CMO) ChartWave Life Sciences Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Wave Life Sciences Ltd. The current willr is -87.42138365.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Wave Life Sciences Ltd Daily Williams %R ChartWave Life Sciences Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Wave Life Sciences Ltd.

Wave Life Sciences Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Wave Life Sciences Ltd. The current atr is 0.38227825.

Wave Life Sciences Ltd Daily Average True Range (ATR) ChartWave Life Sciences Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Wave Life Sciences Ltd. The current obv is 26,912,604.

Wave Life Sciences Ltd Daily On-Balance Volume (OBV) ChartWave Life Sciences Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Wave Life Sciences Ltd. The current mfi is 29.82.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Wave Life Sciences Ltd Daily Money Flow Index (MFI) ChartWave Life Sciences Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Wave Life Sciences Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-17CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-01CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Wave Life Sciences Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Wave Life Sciences Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5035.096
Ma 20Greater thanMa 505.684
Ma 50Greater thanMa 1005.409
Ma 100Greater thanMa 2005.116
OpenGreater thanClose4.920
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Wave Life Sciences Ltd with someone you think should read this too:
  • Are you bullish or bearish on Wave Life Sciences Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Wave Life Sciences Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Wave Life Sciences Ltd

I send you an email if I find something interesting about Wave Life Sciences Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Wave Life Sciences Ltd.

Receive notifications about Wave Life Sciences Ltd in your mailbox!